Asian Spectator

Times Advertising

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

Magazine

Jejak pengetahuan astronomi Nusantara sejak lebih dari 1000 tahun lalu: Dari candi hingga prasasti kuno

● Astronomi Indonesia telah berkembang sejak abad ke-7 dan ke-8 Masehi, jauh sebelum Observatorium Bosscha berdiri pada 1920.● Pendekatan astro-arkeologi mengungkap bahwa orientasi candi e...

Negara berutang pada pemulung atasi persoalan sampah, sudah saatnya membayar jasa lingkungan mereka

● Pemulung berkontribusi besar mengurangi sampah, terutama dari rumah tangga yang merupakan sumber terbesar.● Meski berjasa, pemulung kerap mendapat stigma negatif dari masyarakat. Negara ...

Algorithms don’t care: how AI worsens the double burden for Indonesia’s female gig workers

Artificial intelligence is often celebrated as the future of work. It is efficient, innovative and neutral. Yet, for many women in Indonesia’s gig economy, AI feels like a source of mounting pre...